Breast
cancer is the leading cause of cancer-related mortality
among women. Early stage diagnosis and treatment of this cancer are
crucial to patients’ survival. In addition, it is important
to avoid severe side effects during the process of conventional treatments
(surgery, chemotherapy, hormonal therapy, and targeted therapy) and
increase the patients’ quality of life. Over the past decade,
nanomaterials of all kinds have shown excellent prospects in different
aspects of oncology. Among them, two-dimensional (2D) nanomaterials
are unique due to their physical and chemical properties. The functional
variability of 2D nanomaterials stems from their large specific surface
area as well as the diversity of composition, electronic configurations,
interlayer forces, surface functionalities, and charges. In this review,
the current status of 2D nanomaterials in breast cancer diagnosis
and therapy is reviewed. In this respect, sensing of the tumor biomarkers,
imaging, therapy, and theranostics are discussed. The ever-growing
2D nanomaterials are building blocks for the development of a myriad
of nanotheranostics. Accordingly, there is the possibility to explore
yet novel properties, biological effects, and oncological applications.